Videos Library
Panel Discussion: Payer & provider perspectives on MedTech value demonstration and reimbursement processes
Overview
- Innovative reimbursement models & outcome-based reimbursement feasibility for devices: How far are payers & customers from making this the normal practice?
- Decision making regarding high-cost capital equipment (i.e. imaging technology) as well as surgical implants & in-vitro diagnostics
- Linking health economic benefits to the tendering process: How can manufacturers make their products stand out in a competitive acquisition process?
- Aligning regulatory requirements with the economic evidence needs of payers
- What access opportunities exist for smaller & medium sized MedTech manufacturers & how willing are payers to work with them
Panelists
Soeren Mattke
Managing Director
RAND Corporation
Eric Steager
Director - Corporate Development & Innovation Managing Director, Strategic Innovation Portfolio
Independence Blue Cross
DeChane Dorsey
Vice President, Payment and Health Care Delivery Policy
AdvaMed
Thomas S.Campanella
Director of HealthCare MBA & Professor of Health Economics, Baldwin Wallace University
Of-Counsel for Baker Hostetler, LLP
Sarah Adelman
Vice President
New Jersey Association of Health Plans
Michele de Guise
Director of Health Services and Technology Assessment
INESSS, Canada
Janet McCauley
Senior Medical Director
Blue Cross Blue Shield of North Carolina
Brian Holt
Chief Innovation Officer
IPG, USA
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.